Trial Bolsters Three Drug Combination Treatment as Standard After First Multiple Myeloma Relapse

A new trial confirms the effectiveness of pomalidomide in treating lenalidomide resistant multiple myeloma

Published Jun 7, 2019

NOW
PLAYING
Double Whammy: Heart Attack Associated with Seven Times Higher Cancer Risk in New Study
NOW
PLAYING
New Research Touts Benefits Of DIY Cervical Cancer Test, But Experts Say Not So Fast
NOW
PLAYING
Leading Cancer Specialist Dr. Stephen Hahn Tapped to Run the FDA -- "I've Seen My Grandkids Grow Up Because of Him," Says A Former Patient
NOW
PLAYING
Results From Recent Ovarian Cancer Trial Indicate Big Changes To Come
NOW
PLAYING
New & Exciting Ways To Fight Ovarian Cancer
NOW
PLAYING
"An Important Step": FDA Approves New Combination Treatment For Newly Diagnosed Multiple Myeloma Patients